As of 1:44pm ET
| +0.0487 / +1.10%|
The 1 analysts offering 12-month price forecasts for Orexigen Therapeutics Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +11.39% increase from the last price of 4.49.
The current consensus among 1 polled investment analysts is to Hold stock in Orexigen Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.